Adar1 Capital Management, LLC Renovo Rx, Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 197,250 shares of RNXT stock, worth $203,167. This represents 0.05% of its overall portfolio holdings.
Number of Shares
197,250
Previous 315,192
37.42%
Holding current value
$203,167
Previous $334 Million
23.84%
% of portfolio
0.05%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding RNXT
# of Institutions
21Shares Held
2MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$1 Million0.27% of portfolio
-
Geode Capital Management, LLC Boston, MA236KShares$242,8200.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA141KShares$145,7310.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$100,0790.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny76.8KShares$79,1180.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $9.34M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...